Neoadjuvant immunotherapy shows promise in stage III melanoma

There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.

Telltale dermoscopic features of melanomas lacking pigment reviewed

Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma.

Daily sunscreen use will prevent more melanoma deaths than early detection

“Prevention is low cost, low risk, and effective.”

Sunscreen myths, controversies continue

At the end of the day, "the best sunscreen is the one a patient will use regularly and actually enjoy using."

Hepatocellular carcinoma shows risk factor shift

Demographics, obesity, and metabolic factors have emerged as main drivers of disease.

Serum test sheds light on Merkel cell carcinoma

LAS VEGAS – The rare skin cancer is linked to a subclinical virus and a serum test can offer clinicians useful insight into tumor burden.

Cutaneous squamous cell cancer staging still requires refinement

LAS VEGAS – As cutaneous squamous cell carcinoma draws more attention, two popular staging systems still need refinement.

In Oregon, ‘war on melanoma’ takes flight

LAS VEGAS – Research project hopes to shrink melanoma mortality by emphasizing education, screening.

Researchers working to squash recurrence of superficial BCCs

LAS VEGAS – For now, surgery remains the gold standard of treatment to prevent recurrence.

Melanoma incidence continues to increase, yet mortality stabilizing

LAS VEGAS –Targeted screening efforts that stratify by risk factors and by age “makes screening more efficient and more cost effective.”

Pages